SPDR S&P Biotech ETF
731 hedge funds and large institutions have $9.85B invested in SPDR S&P Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 193 increasing their positions, 280 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
731
Holders Change
-32
Holders Change %
-4.19%
% of All Funds
9.73%
Holding in Top 10
16
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-23.81%
% of All Funds
0.21%
New
101
Increased
193
Reduced
280
Closed
115
Calls
$2.07B
Puts
$3.32B
Net Calls
-$1.26B
Net Calls Change
-$729M
Top Buyers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$1.07B |
| 2 |
2
Citigroup
New York
|
$1B |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$767M |
| 4 |
4
Morgan Stanley
New York
|
$916M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$322M |
